Interesting discussion from WHO Essential Medicines list, to Global Access issues and what Advocacy organisations need to be doing -
most of all Collaborate between disease areas to be all to put pressure on HTA and Reimbursement Authorities
Come up with plans of action to find strategies to put pressure on Regulators and Pharma to talk/negotiate
Get credible data from patients to force access issues to be taken seriously
Who decides what is an essential medicine and patient advocates need to be deeply involved in this area.
If we think access issues are bad in Europe wait until you see the access issues in sub-saharan Africa and India
Collaboration and Transparency.